GSK PLC Sponsored ADR (NYSE:GSK – Get Free Report) announced a quarterly dividend on Tuesday, July 28th. Shareholders of record on Friday, August 14th will be given a dividend of 0.4515 per share by the pharmaceutical company on Thursday, October 8th. This represents a c) dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend is Friday, August 14th. This is a 2.6% increase from GSK’s previous quarterly dividend of $0.44.
GSK has decreased its dividend payment by an average of 0.1%annually over the last three years. GSK has a payout ratio of 36.6% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect GSK to earn $5.14 per share next year, which means the company should continue to be able to cover its $1.77 annual dividend with an expected future payout ratio of 34.4%.
GSK Stock Performance
Shares of NYSE:GSK opened at $50.99 on Wednesday. GSK has a 12-month low of $37.80 and a 12-month high of $61.69. The company’s 50 day moving average price is $51.90 and its two-hundred day moving average price is $53.64. The firm has a market cap of $103.14 billion, a PE ratio of 15.94, a PEG ratio of 2.99 and a beta of 0.36. The company has a quick ratio of 0.52, a current ratio of 0.82 and a debt-to-equity ratio of 0.81.
About GSK
GSK (GlaxoSmithKline plc) is a London-headquartered, multinational pharmaceutical and healthcare company formed through the 2000 merger of Glaxo Wellcome and SmithKline Beecham. The company is dual-listed and operates globally, developing, manufacturing and commercializing prescription medicines, vaccines and specialty treatments. Over its history GSK has evolved through portfolio reshaping and strategic transactions to focus on science-led pharmaceuticals and vaccines.
GSK’s core activities include research and development of therapies and vaccines across a range of therapeutic areas, commercial manufacturing, and global marketing.
See Also
- Five stocks we like better than GSK
- DraftKings’ Predictions Push Could Be the Bet That Matters Most
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
Receive News & Ratings for GSK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GSK and related companies with MarketBeat.com's FREE daily email newsletter.
